The company's P/S surpasses its industry peers, raising conc...
The company's P/S surpasses its industry peers, raising concerns due to its recent negative growth rates. Shareholders may face a tough period unless conditions improve. The falling stock price has brought its P/S back to industry levels, hinting at a potential share price drop.
Hunan Nucien Pharmaceutical Co., Ltd. (SHSE:688189) May Have Run Too Fast Too Soon With Recent 29% Price Plummet
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment